NCT05554367 2026-03-18Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting199 enrolled
NCT03947385 2026-01-27Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsIDEAYA BiosciencesPhase 1/2 Recruiting336 enrolled